Skip to main content

For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding.

Publication ,  Journal Article
Sherwood, M; Piccini, JP
Published in: Evid Based Med
October 2012

Duke Scholars

Published In

Evid Based Med

DOI

EISSN

1473-6810

Publication Date

October 2012

Volume

17

Issue

5

Start / End Page

148 / 149

Location

England

Related Subject Headings

  • General & Internal Medicine
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM

Published In

Evid Based Med

DOI

EISSN

1473-6810

Publication Date

October 2012

Volume

17

Issue

5

Start / End Page

148 / 149

Location

England

Related Subject Headings

  • General & Internal Medicine
  • 3202 Clinical sciences
  • 1103 Clinical Sciences